Nitrogen, upon which all life on Earth depends, may hold the key for explaining how early life on the planet evolved and how it could evolve on other planets.
Omeros Corporation (NASDAQ: OMER) today announced that the first commercial shipments of YARTEMLEA® (narsoplimab-wuug) to its ...
Regenxbio Inc. faces pivotal catalysts in 2026, notably RGX-121's FDA decision and RGX-202 Duchenne data, potentially ...
With star checkpoint inhibitors like Keytruda and Opdivo now sporting subcutaneous formulations, GSK has struck a deal aimed ...
In proppant stability evaluations, LithX mobilized only a very small fraction of edge-bound silica, with no evidence of bulk silica dissolution or catastrophic matrix attack, indicating negligible ...
Investing.com -- Omeros Corporation (NASDAQ:OMER) stock rose 3.1% on Tuesday after the company announced it has completed its ...
For access to the publication, visit: Freeman et al. Real-World Evidence of Growth Improvement in Children 1 to 5 Years of ...
I am a regular blood donor. In the 7-10 days before a donation, I take iron supplements to ensure that my hemoglobin count is sufficient enough to give blood. However, I now think that I have ...
PPT1 is a recombinant protein used to treat an ultra-rare disease called Batten disease CLN1 for which there is ...
Researchers use synthetic biology to reverse-engineer modern nitrogenases and rebuild their possible ancestors, in an effort to better understand the origins of life on Earth and beyond.
Sharp Therapeutics Corp. ("Sharp" or the "Company") (TSX-V: SHRX) (OTCQB: SHRXF), a biotechnology company developing small-molecule therapeutics for genetic diseases, announced today the appointment ...
Unique patent policy, co-funding, and industry mentorship help move discoveries at Rutgers across the “valley of death.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results